Metronidazol Arena

Metronidazole, the active ingredient in Metronidazol Arena, is a nitroimidazole antibiotic presented as an oral dosage form for oral use. It treats a range of anaerobic bacterial and protozoal infections in adults and children as prescribed by a healthcare professional.

GNH USA supplies Metronidazol Arena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Its distribution network ensures timely delivery and regulatory compliance across multiple regions.

Metronidazole is used to treat infections caused by anaerobic bacteria and protozoa.

- Bacterial vaginosis: eliminates the anaerobic bacteria responsible for the condition, relieving symptoms. - Trichomoniasis: eradicates Trichomonas vaginalis, resolving vaginal discharge and irritation. - Amoebiasis: destroys Entamoeba histolytica trophozoites, treating intestinal and extra‑intestinal disease. - Giardiasis: clears Giardia lamblia infection, reducing diarrhea and malabsorption. - Anaerobic bacterial infections: targets a broad spectrum of anaerobes in intra‑abdominal, skin and oral infections. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, aiding clinical recovery.

Metronidazole may cause a variety of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Diarrhea: loose stools that may be watery. - Abdominal cramps: discomfort or cramping in the abdomen. - Headache: mild to moderate headache. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate care. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis, rash, or swelling. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Hepatotoxicity: liver enzyme elevation or injury. - Blood dyscrasias: neutropenia, thrombocytopenia, or anemia.

Before using Metronidazol Arena, consider the following safety measures.

- Pregnancy: consult a healthcare provider as safety data are limited. - Breastfeeding: discuss risks with a clinician; drug may pass into milk. - Alcohol consumption: avoid alcohol during treatment and for at least 48 hours after to prevent a disulfiram‑like reaction. - Liver disease: monitor hepatic function; dose adjustment may be needed. - Renal impairment: assess renal function and adjust dose if required. - Allergy: discontinue immediately if hypersensitivity signs appear. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Metronidazol Arena can interact with several medicines; monitoring is essential.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction with flushing, nausea and tachycardia. - Warfarin: can increase anticoagulant effect; monitor INR closely. - Lithium: may raise lithium levels, increasing risk of toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may elevate metronidazole plasma concentrations. - Phenytoin: may reduce metronidazole efficacy. - Phenobarbital: may lower metronidazole levels, potentially decreasing effectiveness.